PD-L1 Expression: Practical Implications in Lung Cancer

Fred Hirsch, MD, PhD, compares the effectiveness of mono-immunotherapy versus chemotherapy versus immunotherapy + chemotherapy for Non-Small Cell Lung Cancer patients with PD-L1 expression.

Referring a patient is easy. Just click the "Refer a Patient Online" button.

Related Presenters

Fred Hirsch, MD, PhD.

Fred Hirsch, MD, PhD

Director, Center of Excellence for Thoracic Oncology
The Tisch Cancer Institute
Professor of Medicine and Pathology
Icahn School of Medicine at Mount Sinai

View full profile


Related Videos